Insufficient scRNA-seq data for expression of CASP14 at single-cell level.
Insufficient scRNA-seq data for expression of CASP14 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 74% | 37958.61 | 1341 / 1809 | 12% | 33.90 | 56 / 472 |
| prostate | 53% | 134.84 | 129 / 245 | 1% | 0.11 | 3 / 502 |
| breast | 28% | 19.88 | 128 / 459 | 25% | 40.15 | 278 / 1118 |
| uterus | 9% | 24.18 | 16 / 170 | 43% | 161.74 | 198 / 459 |
| pancreas | 35% | 53.44 | 114 / 328 | 14% | 13.23 | 25 / 178 |
| esophagus | 27% | 17.15 | 393 / 1445 | 17% | 27.78 | 31 / 183 |
| bladder | 0% | 0 | 0 / 21 | 32% | 81.40 | 162 / 504 |
| lung | 14% | 11.17 | 81 / 578 | 13% | 10.31 | 145 / 1155 |
| kidney | 20% | 10.83 | 18 / 89 | 3% | 25.39 | 24 / 901 |
| adipose | 18% | 70.86 | 220 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 18% | 27.32 | 243 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 18% | 22.40 | 146 / 803 | 0% | 0 | 0 / 0 |
| heart | 17% | 7.85 | 145 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 16% | 109.94 | 7 / 45 |
| peripheral blood | 16% | 7.14 | 144 / 929 | 0% | 0 | 0 / 0 |
| ovary | 11% | 4.66 | 19 / 180 | 3% | 0.33 | 12 / 430 |
| intestine | 12% | 6.06 | 115 / 966 | 1% | 1.49 | 6 / 527 |
| thymus | 13% | 6.57 | 82 / 653 | 0% | 0 | 0 / 605 |
| stomach | 9% | 3.76 | 32 / 359 | 0% | 0 | 0 / 286 |
| brain | 8% | 4.95 | 224 / 2642 | 0% | 0 | 0 / 705 |
| spleen | 7% | 2.42 | 17 / 241 | 0% | 0 | 0 / 0 |
| liver | 6% | 7.94 | 13 / 226 | 0% | 0.03 | 2 / 406 |
| adrenal gland | 5% | 2.90 | 14 / 258 | 0% | 0 | 0 / 230 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0031424 | Biological process | keratinization |
| GO_0008544 | Biological process | epidermis development |
| GO_0070268 | Biological process | cornification |
| GO_0006508 | Biological process | proteolysis |
| GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
| GO_0001533 | Cellular component | cornified envelope |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0045095 | Cellular component | keratin filament |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005634 | Cellular component | nucleus |
| GO_0004197 | Molecular function | cysteine-type endopeptidase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CASP14 |
| Protein name | Caspase 14, apoptosis-related cysteine peptidase (Caspase-14) (cDNA, FLJ94644, Homo sapiens caspase 14, apoptosis-related cysteine protease(CASP14), mRNA) Caspase 14 Caspase-14 (CASP-14) (EC 3.4.22.-) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form] |
| Synonyms | hCG_38589 |
| Description | FUNCTION: Non-apoptotic caspase involved in epidermal differentiation. Is the predominant caspase in epidermal stratum corneum . Seems to play a role in keratinocyte differentiation and is required for cornification. Regulates maturation of the epidermis by proteolytically processing filaggrin (By similarity). In vitro has a preference for the substrate [WY]-X-X-D motif and is active on the synthetic caspase substrate WEHD-ACF . Involved in processing of prosaposin in the epidermis (By similarity). May be involved in retinal pigment epithelium cell barrier function . Involved in DNA degradation in differentiated keratinocytes probably by cleaving DFFA/ICAD leading to liberation of DFFB/CAD . . |
| Accessions | B2CIS9 A9UFC0 ENST00000427043.4 P31944 |